CHINA MEHECO GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.38 CNY | +3.64% |
|
+3.36% | +1.88% |
| 04-26 | China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
| Sales 2022 | 37.59B 5.19B 414B | Sales 2023 | 38.82B 5.36B 428B | Capitalization | 16.71B 2.31B 184B |
|---|---|---|---|---|---|
| Net income 2022 | 736M 102M 8.11B | Net income 2023 | 1.05B 145M 11.54B | EV / Sales 2022 | 0.71 x |
| Net Debt 2022 | 1.09B 151M 12B | Net Debt 2023 | 1.75B 242M 19.31B | EV / Sales 2023 | 0.48 x |
| P/E ratio 2022 |
35
x | P/E ratio 2023 |
15.9
x | Employees | 8,313 |
| Yield 2022 |
0.86% | Yield 2023 |
-
| Free-Float | 44.6% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.64% | ||
| 1 week | +3.36% | ||
| Current month | +3.36% | ||
| 1 month | +3.36% | ||
| 3 months | +1.25% | ||
| 6 months | -3.97% | ||
| Current year | +1.88% |
1 week
10.76
11.40
1 month
10.4811.63
Current year
9.7812.24
1 year
9.7815.50
3 years
7.4031.61
5 years
7.4031.61
10 years
6.9531.61
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Dong Hu
CEO | Chief Executive Officer | 48 | 29/09/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Min Zhang
BRD | Director/Board Member | 62 | 17/08/22 |
Yong Qiang
CHM | Chairman | 58 | 14/09/09 |
Shao Feng Zhang
BRD | Director/Board Member | 46 | 12-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.47% | 2 M€ | -14.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 11.38 | +3.64% | 32,682,340 |
| 26/04/24 | 10.98 | +0.73% | 12,072,880 |
| 25/04/24 | 10.9 | -0.27% | 7,771,089 |
| 24/04/24 | 10.93 | +0.55% | 9,503,658 |
| 23/04/24 | 10.87 | -1.27% | 10,942,310 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotes
China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.
Sector
Pharmaceuticals
Calendar
| 1st Jan change | Capi. | |
|---|---|---|
| +1.88% | 2.35B | |
| +15.79% | 70.45B | |
| +2.09% | 25.03B | |
| -2.98% | 8.05B | |
| +7.95% | 8.29B | |
| -20.48% | 7.97B | |
| +15.26% | 4.25B | |
| -1.24% | 4.04B | |
| -3.37% | 3.86B | |
| +21.10% | 3.61B |
- Stock Market
- Equities
- 600056 Stock
